CompletedNot Applicable

Libyan Multiple Sclerosis Registry Study

Libya369 participantsStarted 2023-08-02

Plain-language summary

This study aims to understand differences in access to diagnosis and treatment for people with multiple sclerosis (MS) receiving care in Libya. The study uses data from the Libyan Multiple Sclerosis Registry, which collects clinical and treatment information from patients at two tertiary neurology centres. The main focus is to examine how long it takes for patients to receive an MS diagnosis, who has access to high-efficacy disease-modifying therapies, and how these factors relate to disability levels. The results will help identify gaps in MS care within a conflict-affected health system and guide improvements in services for patients in Libya.

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults aged 18 years or older * Diagnosis of multiple sclerosis according to the 2017 McDonald criteria * Receiving care at Tripoli University Hospital or Omar Askar Hospital * Able to provide written informed consent * Recorded EDSS score at registry entry * Availability of core demographic and diagnostic information Exclusion Criteria: * Clinically isolated syndrome (CIS) * Age younger than 18 years * Absence of confirmed multiple sclerosis diagnosis * Missing key clinical variables required for primary analysis (EDSS, phenotype, or DMT information) * Declined or unable to provide informed consent

What they're measuring

Moderate-to-Severe Disability (EDSS ≥3.0)

Timeframe: At registry entry

Moderate-to-Severe Disability (EDSS ≥3.0)

Timeframe: At registry entry

Trial details

NCT IDNCT07264725

SponsorUniversity of Zintan

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-04-30

View on ClinicalTrials.gov More Multiple Sclerosis trials